NCT06383780 2024-07-16Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.Sun Yat-sen UniversityPhase 3 Recruiting90 enrolled
NCT05342792 2022-04-25Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal CarcinomaSun Yat-sen UniversityPhase 3 Recruiting556 enrolled